Vivos Therapeutics (VVOS) EBIT Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.91 Bn | 9.81 Bn | 757.43 Mn | -152.00 |
| 2 | Envista Holdings | 4.28 Bn | 3.15 Bn | 407.00 Mn | 420.00 |
| 3 | Dentsply Sirona | 2.13 Bn | 1.89 Bn | 493.00 Mn | 2,281.00 |
| 4 | Milestone Scientific | 35.27 Mn | 32.66 Mn | 1.56 Mn | 5,119.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.98 Mn | 1.18 Mn | 2.95 Mn | 3,372.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,372.00 |
| Mar 31, 2026 | 124.00 |
| Dec 31, 2025 | -9,101.00 |
| Sep 30, 2025 | -127.00 |
| Jun 30, 2025 | -7,960.00 |
| Mar 31, 2025 | -1,920.00 |
| Dec 31, 2024 | 5,137.00 |
| Sep 30, 2024 | 4,175.00 |
| Jun 30, 2024 | 8,529.00 |
| Mar 31, 2024 | 1,906.00 |
| Dec 31, 2023 | 2,625.00 |
| Sep 30, 2023 | 1,707.00 |
| Jun 30, 2023 | 3,339.00 |
| Mar 31, 2023 | 5,243.00 |
| Dec 31, 2022 | 1,517.00 |
| Sep 30, 2022 | -629.00 |
| Jun 30, 2022 | -7,614.00 |
| Mar 31, 2022 | -8,341.00 |
| Dec 31, 2021 | 2,028.00 |
| Sep 30, 2021 | -6,584.00 |